Arrogene is a sponsor group of 2 issuers that PartnerFacts links to one sponsor (shared people, similar issuer names; automatic match from the filings), filing 20 Form D filings between Sep 2010 and Oct 2019.
What this means One team, 2 deal companies, about 9 years of track record in SEC filings. We link the companies because the same people or address appear on their forms — tap "Request a correction" if that is wrong.
Combined reported sold: $737K to 108 investors (latest filing per issuer). Industries as reported: Biotechnology (2). Issuers are based in CA (2).
What this means $737K raised across the group, about $6,820 per investor. Amounts come from each company's latest Form D; they are what the sponsor reported, not audited figures.
Principal people: Julia Ljubimova (2 issuers, executive officer, director, and promoter), Maurizio Vecchione (2 issuers, executive officer, director, and promoter), Robert Stuckelman (2 issuers, executive officer, director, and promoter), Alexander Ljubimov (1 issuer, executive officer, director, and promoter), Eggehard Holler (1 issuer, executive officer, director, and promoter) and 7 more.
What this means The person on the most companies is usually the one running the show; their page lists every deal.
Activity: 0 new offerings in the last 12 months; latest filing Oct 30, 2019.
What this means No new raise filed in the past year.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA), property records (NYC, FL, IL and TX counties) — none found.
What this means Nothing turned up where we looked (4 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 20 public filings for Arrogene and found 10 differences, 2 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.